04/09/2024
First Participant Dosed in Phase 1 Clinical Trial of Gamma-PN in Older Adults
Adelaide, Australia, 5th September 2024 – GPN Vaccines Ltd is pleased to announce that the first participant has…
News
Read article
21/08/2024GPN Vaccines Secures Ethics Approval for a Clinical Trial of its Pneumococcal Vaccine in Older Adults
Read articleAdelaide, Australia, 21st August 2024 GPN Vaccines is pleased to announce it has received ethics approval to commence…
05/06/2024GPN Vaccines Closes $18M Series B1 Round
Read articleAdelaide, Australia, 6th June 2024 – GPN Vaccines is pleased to announce the closing of its oversubscribed Series…
- 07/05/2024
GPN Vaccines Awarded CUREator Funding
Read articleAdelaide, Australia – 7th May 2024 GPN Vaccines Ltd is pleased to announce the successful award of $936,000…
- 05/02/2024
Dr Erin Brazel Awarded Prestigious Fellowship
Read articleAdelaide, Australia GPN Vaccines is pleased to announce that Dr Erin Brazel has been awarded a Junior Fellowship…
- 03/01/2024
Positive Safety and Immunogenicity Data from Phase 1 Trial of Gamma-PN
Read articleAdelaide, Australia GPN Vaccines Ltd, a clinical-stage biotechnology company developing a Streptococcus pneumoniae vaccine to prevent life-threatening pneumonia, bacteraemia…
